BeStock  
Stocks › TNGX

Tango Therapeutics TNGX

US equityMarket cap rank #2290
$23.08 −$0.16 (-0.69%)
Market closed · Oct 6, 4:10 am ET · Last extended-hours $23.15 +0.30%
Open$23.29
Prev close$23.24
Day range$22.25 – $23.56
Volume1.94M
Market cap$3.89B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00-100.0% YoY
Operating profit-$59.79M-45.9% YoY
Net profit-$55.34M-42.4% YoY
Diluted EPS-$0.37-5.7% YoY
Free cash flow-$38.87M-4.6% YoY
Operating cash flow-$38.87M

Revenue, last 8 quarters

$11.6MSep '24$4.1MDec '24$5.4MMar '25$3.2MJun '25$53.8MSep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-29.2MSep '24$-37.7MDec '24$-39.9MMar '25$-38.9MJun '25$15.9MSep '25$-38.7MDec '25$-45.5MMar '26$-55.3MJun '26

Diluted EPS by quarter

-0.27Sep '24-0.35Dec '24-0.36Mar '25-0.35Jun '250.13Sep '25-0.29Dec '25-0.32Mar '26-0.37Jun '26

Free cash flow by quarter

$-33.5MSep '24$-36.8MDec '24$-41.7MMar '25$-37.1MJun '25$-31.1MSep '25$-29.9MDec '25$-44.4MMar '26$-38.9MJun '26

Profitability & balance sheet

Liabilities / assets4.6%
Cash & investments$1.01B
Total debt$29.05M
Net cash (debt)$984.94M

Balance sheet

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Total Assets $1.07B $435.79M $398.69M $210.14M $237.89M
Payables $1.81M $2.43M $1.18M $2.23M $2.61M
-Accounts Payable $1.81M $2.43M $1.18M $2.23M $2.61M
Current Accrued Expenses $12.71M $7.51M $16.47M $11.38M $9.51M
Short-Term Debt and Capital Lease Obligation $2.94M $2.83M $2.74M $3.10M $2.53M
-Current Capital Lease Obligation $2.94M $2.83M $2.74M $3.10M $2.53M
Other Current Liabilities $2.83M $1.56M $1.29M $1.73M $2.00M
Total Non-Current Liabilities $29.05M $29.96M $30.83M $31.66M $62.91M
Long Term Debt and Capital Lease Obligation $29.05M $29.96M $30.83M $31.66M $32.47M
-Long Term Capital Lease Obligation $29.05M $29.96M $30.83M $31.66M $32.47M
Total Equity $1.02B $391.51M $346.18M $160.03M $134.95M
Total Current Liabilities $20.30M $14.33M $21.68M $18.44M $40.03M
Total Liabilities $49.35M $44.29M $52.51M $50.11M $102.94M
Total Current Assets $1.03B $392.33M $353.76M $163.78M $190.10M
-Cash and Cash Equivalents $345.56M $157.83M $112.28M $58.34M $39.27M
-Short Term Investments $668.43M $222.01M $230.86M $94.47M $141.51M
Restricted Cash $0.00 $0.00 $428,000.00 $428,000.00 $428,000.00
Other Current Assets $17.68M $12.49M $10.19M $10.54M $8.89M
Total Non-Current Assets $42.21M $43.47M $44.93M $46.36M $47.79M
Net PPE $39.76M $41.03M $42.49M $43.93M $45.34M
-Gross PPE $51.04M $51.97M $53.03M $53.99M $54.95M
-Accumulated Depreciation -$11.29M -$10.94M -$10.54M -$10.06M -$9.61M
Other Non-Current Assets $2.45M $2.43M $2.44M $2.43M $2.45M
Stockholders' Equity $1.02B $391.51M $346.18M $160.03M $134.95M
Capital Stock $168,000.00 $144,000.00 $136,000.00 $112,000.00 $111,000.00
-Common Stock $168,000.00 $144,000.00 $136,000.00 $112,000.00 $111,000.00
Additional Paid-In Capital $1.73B $1.04B $948.97M $724.20M $715.04M
Retained Earnings -$704.01M -$648.67M -$603.15M -$564.40M -$580.29M
Gains/Losses Not Affecting Retained Earnings -$633,000.00 -$115,000.00 $224,000.00 $121,000.00 $94,000.00
Cash and Cash Equivalents & Short-Term Investments $1.01B $379.84M $343.14M $152.81M $180.79M
Convertible preferred securities $0.00 $0.00 $0.00 $0.00 $0.00
Non-Current Deferred Liabilities – – $0.00 $0.00 $30.44M
Current Deferred Liabilities – – $0.00 $0.00 $23.37M

Income statement

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Other Non-Operating Income (Expenses) $722,000.00 $1.08M $1.38M $705,000.00 $910,000.00
Other Income (Expense) $722,000.00 $1.08M $1.38M $705,000.00 $910,000.00
Non-Operating Interest Income $3.72M $2.18M $1.68M $1.10M $1.24M
Net Non-Operating Interest Income (Expense) $3.72M $2.18M $1.68M $1.10M $1.24M
Operating Profit -$59.79M -$48.77M -$41.86M $14.07M -$40.97M
Research & Development $37.20M $33.53M $32.10M $30.82M $32.81M
Selling and Admin Expenses $22.59M $15.24M $9.76M $8.92M $11.34M
Operating Expense $59.79M $48.77M $41.86M $39.74M $44.15M
Total Operating Revenue $0.00 $0.00 $0.00 $53.81M $3.18M
Total Revenue as Reported $0.00 $0.00 $0.00 $53.81M $3.18M
Pretax Profit -$55.34M -$45.51M -$38.80M $15.87M -$38.82M
Tax $1,000.00 $1,000.00 -$55,000.00 -$10,000.00 $35,000.00
Diluted EPS -$0.37 -$0.32 -$0.29 $0.13 -$0.35
Basic EPS -$0.37 -$0.32 -$0.29 $0.14 -$0.35
Net Income to Common Stockholders -$55.34M -$45.51M -$38.75M $15.88M -$38.85M
Profit from Continuing Operations -$55.34M -$45.51M -$38.75M $15.88M -$38.85M
Net Profit -$55.34M -$45.51M -$38.75M $15.88M -$38.85M
-General & Admin Expense $22.59M $15.24M $9.76M $8.92M $11.34M
Net Income to Parent Company -$55.34M -$45.51M -$38.75M $15.88M -$38.85M

Cash flow

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Free Cash Flow -$38.87M -$44.36M -$29.94M -$31.10M -$37.14M
Net PPE Purchase and Sale $20,000.00 $2,000.00 -$222,000.00 -$151,000.00 -$624,000.00
Operating Cash Flow -$38.87M -$44.36M -$29.72M -$30.95M -$36.52M
Net Cash Flow from Continuing Financing Activities $672.57M $79.85M $219.38M $2.54M $581,000.00
Net Common Stock Issuance $652.04M $62.78M $212.40M $0.00 $0.00
Financing Cash Flow $672.57M $79.85M $219.38M $2.54M $581,000.00
Proceeds from Stock Option Exercised $20.62M $17.61M $7.01M $2.54M $581,000.00
Net Other Financing Charges -$95,000.00 -$537,000.00 – – –
Ending Cash Balance $347.70M $159.97M $114.85M $60.91M $41.84M
Net Change in Cash $187.73M $45.12M $53.94M $19.07M -$19.16M
Net cash flow from continuing operations -$38.87M -$44.36M -$29.72M -$30.95M -$36.52M
Net Income from Continuing Operations -$55.34M -$45.51M -$38.75M $15.88M -$38.85M
Net Cash Flow from Continuing Investing Activities -$445.97M $9.64M -$135.72M $47.48M $16.78M
Net cash flow from investing -$445.97M $9.64M -$135.72M $47.48M $16.78M
-Change in Other Current Liabilities -$797,000.00 -$781,000.00 -$1.19M -$245,000.00 -$814,000.00
-Change in Other Current Assets -$19,000.00 $10,000.00 -$13,000.00 $20,000.00 -$307,000.00
-Change in Prepaid Assets -$5.19M -$2.30M $350,000.00 -$1.65M -$1.11M
Net Investment Purchase and Sale -$445.99M $9.63M -$135.50M $47.63M $17.40M
Other Non-Cash Items $970,000.00 $993,000.00 $939,000.00 $972,000.00 $1.02M
Depreciation & Depletion & Amortization $425,000.00 $463,000.00 $479,000.00 $555,000.00 $625,000.00
Beginning Cash Balance $159.97M $114.85M $60.91M $41.84M $61.00M
Change in Working Capital -$866,000.00 -$9.98M $2.40M -$54.43M -$5.16M
-Change in Payables and Accrued Expense $5.14M -$6.91M $3.26M $1.26M $256,000.00
-Change In Other Working Capital – – $0.00 -$53.81M -$3.18M

Discussion

No comments yet — be the first to weigh in on TNGX.

Leave a comment

Scroll to Top